Kura Oncology
KURA
198 hedge funds and large institutions have $2.12B invested in Kura Oncology in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 75 increasing their positions, 56 reducing their positions, and 15 closing their positions.
258% more call options, than puts
Call options by funds: $23.5M | Put options by funds: $6.58M
253% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 15
34% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 56
29% more capital invested
Capital invested by funds: $1.65B → $2.12B (+$476M)
22% more funds holding
Funds holding: 162 → 198 (+36)
4.73% more ownership
Funds ownership: 95.63% → 100.36% (+4.7%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$66M |
| 2 |
RI
RTW Investments
New York
|
+$59.8M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$55M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$37.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$36.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$99.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$46M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$25.1M |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$20.5M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$18.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
201
WCM Investment Management
Laguna Beach,
California
| – | -$4.27M | -139,462 | Closed |
|
|
PM
202
Prosight Management
Dallas,
Texas
| – | -$3.29M | -107,367 | Closed |
|
|
AA
203
ALPS Advisors
Denver,
Colorado
| – | -$2.2M | -71,775 | Closed |
|
|
JGC
204
J. Goldman & Co
New York
| – | -$779K | -25,425 | Closed |
|
205
SEI Investments
Oaks,
Pennsylvania
| – | -$716K | -23,353 | Closed |
|
|
TC
206
Telemus Capital
Southfield,
Michigan
| – | -$682K | -20,000 | Closed |
|
|
LCM
207
Laurion Capital Management
New York
| – | -$319K | -10,400 | Closed |
|
|
CCIA
208
Campbell & Co Investment Adviser
Baltimore,
Maryland
| – | -$289K | -9,429 | Closed |
|
|
MAM
209
Meeder Asset Management
Dublin,
Ohio
| – | -$155K | -5,069 | Closed |
|
|
SM
210
SG3 Management
Dorado,
Puerto Rico
| – | -$176K | -5,000 | Closed |
|
|
IA
211
IFP Advisors
Tampa,
Florida
| – | -$92.3K | -2,628 | Closed |
|
|
ASN
212
Advisory Services Network
Atlanta,
Georgia
| – | -$4.04K | -115 | Closed |
|
|
CWC
213
Carolinas Wealth Consulting
Charlotte,
North Carolina
| – | -$1K | -37 | Closed |
|
KURA Hedge Fund Activity: Q4 2020 in Review
198 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2020, worth a combined $2.12B — up 29% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new KURA positions and 15 closed out — a net gain of 38 holders — while 75 added to existing stakes and 56 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $66M. The largest seller was EcoR1 Capital, cutting an estimated $99.6M.
- 198 institutional investors held Kura Oncology (KURA) as of Q4 2020, up from 162 in Q3 2020.
- Funds reported $2.12B of Kura Oncology stock for Q4 2020, up 29% quarter-over-quarter.
- 53 funds opened new Kura Oncology positions in Q4 2020 and 15 closed out, a net change of +38 holders.
- The largest Kura Oncology buyer in Q4 2020 was Fidelity Investments, an estimated $66M added.
- The largest Kura Oncology seller in Q4 2020 was EcoR1 Capital, an estimated $99.6M sold.
Based on aggregated 13F filings for Q4 2020.